Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 35 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 9 | 303−1.5%/yr | −1.5%/yr | 1.40.4× | 0% | 330 in 2030+1.5%/yr |
| Decompression & minimally invasive spine | 6 | 276−14%/yr | −14%/yr | 1.30.4× | 0% | 310 in 2030+2.1%/yr |
| Cervical fusion & disc arthroplasty | 2 | 183−11%/yr | −11%/yr | 0.80.5× | 0% | 160 in 2030−2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 70 | 14,070−5.5%/yr | −5.5%/yr | 64.10.5× | 37% | 13,100 in 2030−1.2%/yr |
| Skin substitutes & wound grafts | 12 | 3,280+21%/yr | +21%/yr | 9.30.8× | 82% | 4,240 in 2030+4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 24 | 1,871−2.4%/yr | −2.4%/yr | 8.50.6× | 17% | 2,300 in 2030+3.5%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 3 | 158+6.2%/yr | +6.2%/yr | 0.70.5× | 27% | 100 in 2030−7%/yr |
| Spinal cord & DRG stimulation | 1 | 120−14%/yr | −14%/yr | 0.50.6× | 0% | 120 in 2030+0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 5 | 769−11%/yr | −11%/yr | 3.50.6× | 0% | 840 in 2030+1.4%/yr |
| Carotid revascularization | 5 | 402−5.6%/yr | −5.6%/yr | 1.91.5× | 0% | 380 in 2030−1%/yr |
| Superficial venous ablation | 6 | 374−9.4%/yr | −9.4%/yr | 1.70.3× | 83% | 400 in 2030+1%/yr |
| Dialysis access | 2 | 305−22%/yr | −22%/yr | 1.50.3× | 0% | 350 in 2030+2.3%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 251−3%/yr | −3%/yr | 1.20.7× | 0% | 280 in 2030+1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 8 | 821−8.3%/yr | −8.3%/yr | 4.20.7× | 0% | 620 in 2030−4.5%/yr |
| Cholecystectomy & appendectomy | 19 | 820−11%/yr | −11%/yr | 4.00.9× | 0% | 720 in 2030−2.2%/yr |
| Colorectal resection | 0 | 265−9.2%/yr | −9.2%/yr | 1.30.8× | 0% | 200 in 2030−4.7%/yr |
| Antireflux & hiatal hernia surgery | 2 | 134−13%/yr | −13%/yr | 0.60.8× | 0% | 100 in 2030−5.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 21 | 920−7.2%/yr | −7.2%/yr | 4.50.9× | 0% | 990 in 2030+1.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 4 | 616−2.8%/yr | −2.8%/yr | 3.21.2× | 5% | 580 in 2030−1.1%/yr |
| BPH procedures | 11 | 613−15%/yr | −15%/yr | 2.90.6× | 0% | 420 in 2030−6.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 6 | 311−5%/yr | −5%/yr | 1.50.6× | 0% | 360 in 2030+2.4%/yr |
| Prostatectomy & nephrectomy | 1 | 137+2.2%/yr | +2.2%/yr | 0.70.6× | 0% | 260 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 1 | 228−14%/yr | −14%/yr | 1.10.2× | 55% | 150 in 2030−6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 16 | 949−6.7%/yr | −6.7%/yr | 4.90.7× | 8% | 890 in 2030−1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 43 | 4,488+28%/yr | +28%/yr | 21.10.7× | 34% | 8,070 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 18 | 1,108−1.5%/yr | −1.5%/yr | 5.51.0× | 0% | 1,020 in 2030−1.4%/yr |
| EP ablation | 13 | 643+7.7%/yr | +7.7%/yr | 2.60.7× | 0% | 1,120 in 2030+9.8%/yr |
| LAA occlusion & loop recorders | 16 | 642+15%/yr | +15%/yr | 2.60.7× | 0% | 980 in 2030+7.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 36 | 1,595−10%/yr | −10%/yr | 6.21.0× | 0% | 1,560 in 2030−0.4%/yr |
| Structural heart (TAVR, TEER) | 12 | 269+1.5%/yr | +1.5%/yr | 1.10.7× | 0% | 460 in 2030+9.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 40 | 8,511−8.6%/yr | −8.6%/yr | 40.00.7× | 46% | 6,820 in 2030−3.6%/yr |
| Vitreoretinal surgery | 4 | 208−16%/yr | −16%/yr | 1.00.4× | 73% | 310 in 2030+6.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 90 | 15,764−9.7%/yr | −9.7%/yr | 78.60.7× | 4% | 14,300 in 2030−1.6%/yr |
| ERCP & endoscopic ultrasound | 12 | 913−4.3%/yr | −4.3%/yr | 4.51.4× | 0% | 1,000 in 2030+1.5%/yr |
| Bronchoscopy & lung nodule | 4 | 478−5.3%/yr | −5.3%/yr | 2.30.7× | 0% | 670 in 2030+5.8%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.